It is a healthcare private limited company based in Indore, Madhya Pradesh, India, established in 2022.
2022 | Indore, Madhya Pradesh, India | ActivePharmiza Drugs Private Limited, a active private limited company, was established on 29 September 2022 in Indore, Madhya Pradesh, India. Engaging in manufacturing within the healthcare sector, it holds CIN: U33100MP2022PTC062919. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Khalid Sheikh (Director), Aves Pathan (Director), Shakib Pathan (Director). Past directors included Naved Khan, Mazhar Agwan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6, Deep Palace Colony,, Pipliya Kumar,, Indore, Madhya Pradesh, 452010.
U33100MP2022PTC062919
062919
29 September 2022
₹1.50 M
₹0.10 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Pharmiza Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Khalid Sheikh | Director | 29 Sep 2022 | Current |
| Aves Pathan | Director | 29 Sep 2022 | Current |
| Shakib Pathan | Director | 29 Sep 2022 | Current |
| Mazhar Agwan | Director | 27 Oct 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Dec 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Pharmiza Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Pharmiza Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Pharmiza Drugs has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pharmiza Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmiza Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Pharmiza Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Pharmiza Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.
The activity Mazhar Agwan was appointed as a Director was appointed as a Director on 27 Oct 2022 & has been associated with this company since 3 years 1 month . was completed.
Khalid Sheikh was appointed as a Director was appointed as a Director on 29 Sep 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.
The activity Aves Pathan was appointed as a Director was appointed as a Director on 29 Sep 2022 & has been associated with this company since 3 years 2 months . was completed.
The activity Shakib Pathan was appointed as a Director was appointed as a Director on 29 Sep 2022 & has been associated with this company since 3 years 2 months . was completed.
The CIN of Pharmiza Drugs Private Limited is U33100MP2022PTC062919.
Pharmiza Drugs Private Limited is headquartered at 6, Deep Palace Colony,, Pipliya Kumar,, Indore, Madhya Pradesh, 452010.
Pharmiza Drugs Private Limited was incorporated on 29 September 2022.
The current directors of Pharmiza Drugs Private Limited are
The primary industry of Pharmiza Drugs Private Limited is Healthcare.
Pharmiza Drugs Private Limited is unlisted.
The authorized capital of Pharmiza Drugs Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX